Live Tonight: Lyme Disease & Chronic Pain Webinar

June 17, 2020

Live Webinar: Lyme Disease & Chronic Pain – Dr. Bill Rawls

erasing pain, hand written word on blackboard being erased concept

The list of symptoms that can come with chronic Lyme disease is long and varied, but pain — in the joints, muscles, nerves, neck, eyes, even teeth — seems to be a common denominator.

Why are Lyme sufferers so prone to chronic pain, and what can you do to find fast and lasting relief?

Join a live webinar with Dr. Bill Rawls, author of the bestselling book Unlocking Lyme, who knows firsthand what it’s like to live with chronic Lyme disease and related aches and pains. He’ll shed new light on the underlying forces that drive persistent pain, and share natural ways to resolve them so you’re not just managing discomfort, but overcoming it.

PLUS: Don’t miss an exclusive gift for webinar attendees, and have your questions ready for a LIVE Q&A on Lyme and chronic pain with Dr. Rawls.

Watch June 17th, 8pm EDT

Lyme & Chronic Pain – Live Webinar

  • The causes and telltale symptoms of different types of pain
  • How Borrelia burgdorferi and common Lyme coinfections like Mycoplasma, Bartonella, and Babesia contribute to pain
  • The best herbs and natural remedies for immediate and long-term relief
  • Additional diet and lifestyle tips to help keep symptoms at bay 
  • Numerous insights during the live Q&A with Dr. Rawls 

RESERVE MY SEAT »

___________________

For more:

Category:

Herbs, Lyme, Pain Management, Supplements

Comments Off on Live Tonight: Lyme Disease & Chronic Pain Webinar

How Google is Manipulating COVID Related Search Results

https://www.greenmedinfo.com/blog/how-google-manipulating-covid-related-search-results?

How Google is Manipulating COVID Related Search Results

Written By:  Sayer Ji, Founder
© [June 11, 2020] GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here //www.greenmedinfo.com/greenmed/newsletter.”

Amazingly, most users of Google still don’t understand the powerful spell that the Search Engine Manipulation Effect (SEME) holds over their minds and behavior. When it comes to COVID, it’s no less egregious, and it’s more important now than ever to question everything: https://questioningcovid.com/

Referenced material:

  1. https://www.greenmedinfo.com/blog/google-just-obliterated-natural-and-health-freedom-websites-its-search-results-wh
  2. https://www.greenmedinfo.com/blog/how-google-uses-mind-control-tactics-promote-pro-vaccine-industry-propaganda https://www.greenmedinfo.com/blog/did-googles-manipulation-sway-vaccine-legislation
  3. https://trends.google.com/trends/explore?q=covid%20is%20a%20scam,covid%20is%20almost%20over
  4. https://www.blog.google/products/search/how-google-autocomplete-works-search/

_____________________

For more:  https://madisonarealymesupportgroup.com/2020/06/10/misdiagnosis-censorship-and-contact-tracing/

https://madisonarealymesupportgroup.com/2020/05/05/censored-doc-doubles-down/

https://madisonarealymesupportgroup.com/2019/06/04/censorship-is-the-last-tool-of-tyrants/

https://madisonarealymesupportgroup.com/2020/05/20/how-bill-gates-controls-global-messaging-and-censorship/

https://madisonarealymesupportgroup.com/2020/05/30/global-health-mafia-protection/

https://madisonarealymesupportgroup.com/2020/06/06/lockdown-lunacy-the-thinking-persons-guide/

https://madisonarealymesupportgroup.com/2019/11/11/video-exposing-googles-racketeering-and-anti-trust-fraud-against-health-publishers/

https://madisonarealymesupportgroup.com/2017/01/30/government-censorship-vaccines/

 

 

Category:

Activism, Viruses

Comments Off on How Google is Manipulating COVID Related Search Results

Herd Immunity May Only Need 10-20% of People to Be Infected

https://www.spectator.co.uk/article/herd-immunity-may-only-need-a-10-per-cent-infection-rate

Herd immunity may only need 10-20 per cent of people to be infected

Written by Ross Clark
Since mid-March there has been an assumption that herd immunity against Covid-19 would not be achieved until around 60 per cent of the population has been infected. It is a figure which gave rise to the now-famous paper by Professor Neil Ferguson of Imperial College, which claimed that a herd immunity policy (which the government denies ever following) would result in the deaths of 250,000 people in Britain. That figure has been challenged by scientists who have questioned some of the assumptions behind it – for example, it assumed a mortality rate of 0.9 per cent which Imperial College itself has since revised downwards to 0.66 per cent, and some believe is lower still. (See link for article)

____________________

**Comment**

Important quote:

If herd immunity really is achieved at between 10 to 20 per cent it could mean that many parts of the world are approaching it – or are there already.

It would also make a vaccine completely and utterly unwarranted yet we are being held hostage until this supposed “magic button” that’s been fast-tracked bypassing important safety studies.

For more:  https://madisonarealymesupportgroup.com/2020/06/10/covid-vaccine-what-else-could-they-put-in-the-shot/

https://madisonarealymesupportgroup.com/2020/04/21/inovio-covid-19-vaccine-uses-electricity-to-drive-dna-into-body-cells/ DNA (and RNA) vaccines have been available and approved for veterinary medicine, but none have yet been approved for human use. 

The World Health Organization (WHO) acknowledges there are gaps in scientific knowledge about DNA vaccines and states:22

Many aspects of the immune response generated by DNA vaccines are not understood.However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Some of the outstanding questions about DNA vaccine safety include:23

  • chronic inflammationbecause the vaccine continually stimulates the immune system to produce antibodies;
  • possible integration of plasmid DNA into the body’s host genome resulting in mutations;
  • problems with DNA replication;
  • triggering of autoimmune responses, and
  • activation of cancer-causing genes.

https://madisonarealymesupportgroup.com/2020/05/23/uk-vaccine-unable-to-prevent-monkeys-from-catching-covid-19/

https://madisonarealymesupportgroup.com/2020/04/30/sound-choice-pharmaceutical-newsletter-covid-19-safety-concerns/

https://madisonarealymesupportgroup.com/2020/06/04/covid-19-is-a-vaccine-the-answer/

https://madisonarealymesupportgroup.com/2020/05/14/dod-hhs-award-138-million-for-project-jumpstart-rapid-usa-for-prefilled-covid-19-vaccine-syringes/

Category:

Activism, Viruses

Comments Off on Herd Immunity May Only Need 10-20% of People to Be Infected

Co-infections Among COVID-19 Patients: The Need for Combination Therapy With Non-Anti-SARS-CoV-2 Agents?

https://www.sciencedirect.com/science/article/pii/S1684118220301274

Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?

Under a Creative Commons license
open access

Abstract

Co-infection has been reported in patients with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome, but there is limited knowledge on co-infection among patients with coronavirus disease 2019 (COVID-19). The prevalence of co-infection was variable among COVID-19 patients in different studies, however, it could be up to 50% among non-survivors. Co-pathogens included bacteria, such as

  • Streptococcus pneumoniae
  • Staphylococcus aureus
  • Klebsiella pneumoniae
  • Mycoplasma pneumoniae
  • Chlamydia pneumonia
  • Legionella pneumophila
  • Acinetobacter baumannii
  • Candida species
  • Aspergillus flavus
  • viruses such as influenza, coronavirus, rhinovirus/enterovirus, parainfluenza, metapneumovirus, influenza B virus, and human immunodeficiency virus

Influenza A was one of the most common co-infective viruses, which may have caused initial false-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Laboratory and imaging findings alone cannot help distinguish co-infection from SARS-CoV-2 infection. Newly developed syndromic multiplex panels that incorporate SARS-CoV-2 may facilitate the early detection of co-infection among COVID-19 patients. By contrast, clinicians cannot rule out SARS-CoV-2 infection by ruling in other respiratory pathogens through old syndromic multiplex panels at this stage of the COVID-19 pandemic. Therefore, clinicians must have a high index of suspicion for coinfection among COVID-19 patients. Clinicians can neither rule out other co-infections caused by respiratory pathogens by diagnosing SARS-CoV-2 infection nor rule out COVID-19 by detection of non-SARS-CoV-2 respiratory pathogens.

After recognizing the possible pathogens causing co-infection among COVID-19 patients, appropriate antimicrobial agents can be recommended.

_____________________

**Comment**

This would explain why COVID-19 does not resemble a simple virus, just as Lyme disease doesn’t present identically from individual to individual. Lyme/MSIDS is also best treated with combination therapy; however, most regular practitioners follow the antiquated and unscientific CDC treatment guidelines which haven’t worked for over 40 years (which in a nutshell is 21 days of doxycycline for all despite body weight and coinfections).

With each day there seems to be more and more similarities to Lyme/MSIDS in that cases are complex and individual. Medicine needs to acknowledge and embrace this complexity:  https://madisonarealymesupportgroup.com/2020/04/26/cdc-playbook-learning-from-lyme/

This also explains why things like antibiotics and anti-parasitics work.  The pathogen list did not include tick-borne pathogens but should, as undoubtedly many of these people could very well have undiagnosed infections that COVID-19, much like vaccines, can reactivate latent infections: https://madisonarealymesupportgroup.com/2017/12/02/scottish-doctor-gives-insight-on-lyme-msids/

Category:

Candida, Mycoplasma, research, Treatment, Viruses

Comments Off on Co-infections Among COVID-19 Patients: The Need for Combination Therapy With Non-Anti-SARS-CoV-2 Agents?

Borrelia Miyamotoi Infection in a Highly Endemic Area of Lyme Disease

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260789/

Published online 2020 May 30. doi: 10.1186/s12941-020-00364-0
PMCID: PMC7260789
PMID: 32473652

Presence of Borrelia miyamotoi infection in a highly endemic area of Lyme disease

Luis A. Marcos,corresponding author1,2 Kalie Smith,1 Kelsey Reardon,1 Fredric Weinbaum,3 and Eric D. Spitzer4

Abstract

A series of cases in the Northeast of the US during 2013–2015 described a new Borrelia species, Borrelia miyamotoi, which is transmitted by the same tick species that transmits Lyme disease and causes a relapsing fever-like illness. The geographic expansion of B. miyamotoi in the US also extends to other Lyme endemic areas such as the Midwestern US. Co-infections with other tick borne diseases (TBD) may contribute to the severity of the disease. On Long Island, NY, 3–5% of ticks are infected by B. miyamotoi, but little is known about the frequency of B. miyamotoi infections in humans in this particular region. The aim of this study was to perform a chart review in all patients diagnosed with B. miyamotoi infection in Stony Brook Medicine (SBM) system to describe the clinical and epidemiological features of B. miyamotoi infection in Suffolk County, NY. In a 5 year time period (2013–2017), a total of 28 cases were positive for either IgG EIA (n = 19) or PCR (n = 9).

All 9 PCR-positive cases (median age: 67; range: 22–90 years) had clinical findings suggestive of acute or relapsing infection.

All these patients were thought to have a TBD, prompting the healthcare provider to order the TBD panel which includes a B. miyamotoi PCR test.

In conclusion, B. miyamotoi infection should be considered in the differential diagnosis for flu-like syndromes during the summer after a deer tick bite and to prevent labeling a case with Lyme disease.

__________________

**Comment**

https://madisonarealymesupportgroup.com/2018/09/04/borrelia-miyamotoi-in-immunocompetent-patient/

Dr. Cameron states:  “Until now, there have been no treatment guidelines for B. miyamotoi and regimes have been empirically based on the treatment for Lyme disease. ‘The antimicrobial susceptibility of B. miyamotoi has not yet been elucidated, due to difficulties with cultivation of B. miyamotoi spirochetes in vitro,’ according to Koetsveld.  http://danielcameronmd.com/best-antibiotics-treat-borrelia-miyamotoi/  The study authors demonstrated that B. miyamotoi is susceptible to doxycycline, azithromycin, and ceftriaxone but resistant to amoxicillin in vitro. The next step would be to show whether these drugs work in patients.”

For more:  https://madisonarealymesupportgroup.com/category/borrelia-miyamotoi-relapsing-fever-group/http://danielcameronmd.com/dont-count-on-a-relapsing-fever-to-diagnose-borrelia-miyamotoi/
“You might assume a patient infected with Borrelia miyamotoi, a relapsing fever spirochete, to present with a relapsing fever. However, your assumption would be wrong 48 out of 50 times, according to a case series published in the Annals of Internal Medicine. [1] The authors found that only 2 out of 50 patients infected with the relapsing spirochete B. miyamotoi actually presented with a relapsing fever. [1]….The individuals exhibited symptoms similar to those found in other tick-borne illnesses.
The majority presented with headaches, myalgias, arthralgias, and malaise/fatigue. ‘More than 50% were suspected of having sepsis, and 24% required hospitalization,’ states Molloy. [1]…..’Serologic testing using the rGlpQ EIA seems insensitive in diagnosing acute BMD infection given that it was positive for IgG or IgM in only 16% of the case patient samples at the time of clinical presentation,’ states Molloy. The rGlpQ was positive after the fact in 86% of the patients during convalescence. [1]….Elevated liver enzyme levels, neutropenia, and thrombocytopenia were common in 75%, 60% and 51% respectively.
‘Borrelia miyamotoi disease may be clinically similar to or be confused with human anaplasmosis,’ according to Molloy….B. miyamotoi has emerged as a leading cause of hard tick-transmitted infections but lacks a clear diagnostic criteria. According to Molloy, “Infection with B. miyamotoi is the fifth recognized Ixodes-transmitted infection in the northeastern United States and should be part of the differential diagnosis of febrile patientsfrom areas where deer tick–transmitted infections are endemic.’”

Category:

Borrelia Miyamotoi (Relapsing Fever Group), Lyme, research

Comments Off on Borrelia Miyamotoi Infection in a Highly Endemic Area of Lyme Disease